KP Tissue Inc. (TSE:KPT - Get Free Report) shares reached a new 52-week high on Monday . The stock traded as high as C$11.06 and last traded at C$11.06, with a volume of 4411 shares changing hands. The stock had previously closed at C$10.99.
Wall Street Analysts Forecast Growth
Separately, National Bank Financial increased their price objective on shares of KP Tissue from C$10.00 to C$11.00 and gave the stock a "sector perform" rating in a research report on Monday, February 2nd. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of C$10.25.
View Our Latest Research Report on KPT
KP Tissue Price Performance
The stock has a market cap of C$110.31 million, a P/E ratio of 13.01, a P/E/G ratio of -0.88 and a beta of 0.49. The company has a fifty day moving average price of C$10.64 and a 200 day moving average price of C$10.12.
KP Tissue (TSE:KPT - Get Free Report) last issued its earnings results on Wednesday, February 18th. The company reported C$0.26 earnings per share for the quarter. As a group, sell-side analysts expect that KP Tissue Inc. will post 0.4398964 earnings per share for the current fiscal year.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.